Search International and National Patent Collections
Some content of this application is unavailable at the moment.
If this situation persists, please contact us atFeedback&Contact
1. (WO2017096304) SLC45A2 PEPTIDES FOR IMMUNOTHERAPY
Available information on National Phase entries(more information)
OfficeEntry DateNational NumberNational Status
Canada 01.06.20183007301
Japan 01.06.20182018528745
Singapore 01.06.201811201804648R
Israel 04.06.2018259793
Australia 05.06.20182016363006Published: 28.06.2018
European Patent Office 04.07.20182016871668Published: 10.10.2018
Republic of Korea1020187018329Published: 30.10.2018
United States of America15780597Published: 06.06.2019